Esperion Therapeutics, Inc. (ESPR)
3.15
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
3.13
-0.02
(-0.63%)
After-Hours: 20:00
Esperion Therapeutics SG&A Expense (TTM) : 165.79M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 68.67M |
| Merck & Co., Inc. | 10.88B |
| Harrow, Inc. | 152.91M |
| Corcept Therapeutics, Inc. | 503.42M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |